Mekos Laboratories AS: Clinical Trials

2 completed. 2 Phase 2.

By phase and status

Phase	Trials	Status
Phase 2	2	Completed 2

Follow Mekos Laboratories AS: new trials by email

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

Trial	Phase	Status	Sponsor	Enrollment	Start	Updated
Clinical Evaluation of the 3 Allergens: Methyldibromoglutharonitrile, Parthenolide and Goldnatriumthiosulphate Goldnatriomthiosulphate, MDBGN, parthenolide - Allergic Contact Dermatitis	Phase 2	Completed	Mekos Laboratories AS	60	2005-04-01	2006-02-27
Clinical Evaluation of Bacitracin bacitracin (allergen) - Allergic Contact Dermatitis	Phase 2	Completed	Mekos Laboratories AS	20	2005-04-01	2005-10-19

Conditions studied

Dermatitis, Allergic Contact (2)

Interventions

1,2-dibromo-2,4-dicyanobutane (1)  ·  Allergens (1)  ·  Bacitracin (1)  ·  parthenolide (1)

Countries

Denmark (1)  ·  United States (1)

Top investigators

Joseph Fowler, Prof. (1)  ·  Klaus E Andersen, Prof. (1)